Clinical Trial Update: Single-cell CBD Biomarkers of Inflammation Reduction in People Living With HIV [Phase 4]

View source ↗

Summary

Phase 4 trial investigating single-cell CBD biomarkers of inflammation reduction in people living with HIV has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Inflammation

Drugs mentioned

• CBD (cannabidiol)

Snippet

Sponsor: University of Florida | Conditions: Chronic Inflammation | Phase 4 | Status: COMPLETED | Results posted: 2023-12-28